Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06446661 · ClinicalTrials.gov registry record · NA
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
A NA study, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT06446661 is a NA study that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 48 participants.
The verdict
NCT06446661, a NA study, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Interventions
- OTHER High Intensity
- OTHER No Text Messagings
- OTHER Low Intensity Text Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-05-19 |
| Est. Completion | 2028-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06446661
The ClinicalTrials.gov registry entry for NCT06446661 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High Intensity is the first listed.
NCT06446661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06446661 about?
NCT06446661 is a clinical study titled "Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia". This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
What is the current status of trial NCT06446661?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2026-05-19. Estimated completion is 2028-06-15.
What interventions are being tested in trial NCT06446661?
The interventions under investigation include: High Intensity (OTHER), No Text Messagings (OTHER), Low Intensity Text Messaging (OTHER).
Who is sponsoring clinical trial NCT06446661?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.